发明授权
US07923467B2 Substituted pyrrole derivatives and their use as HMG-CO inhibitors
失效
取代的吡咯衍生物及其用作HMG-CO抑制剂
- 专利标题： Substituted pyrrole derivatives and their use as HMG-CO inhibitors
- 专利标题（中）： 取代的吡咯衍生物及其用作HMG-CO抑制剂
-
申请号： US10558859申请日： 2004-05-28
-
公开(公告)号： US07923467B2公开(公告)日： 2011-04-12
- 发明人: Mohammad Salman , Jitendra Sattigeri , Yatendra Kumar , Ram Chander Aryan , Vikram Krishna Ramanathan , Anita Chugh
- 申请人： Mohammad Salman , Jitendra Sattigeri , Yatendra Kumar , Ram Chander Aryan , Vikram Krishna Ramanathan , Anita Chugh
- 申请人地址： IN New Delhi, Delhi
- 专利权人： Ranbaxy Laboratories, Inc.
- 当前专利权人： Ranbaxy Laboratories, Inc.
- 当前专利权人地址： IN New Delhi, Delhi
- 代理机构： Sheridan Ross, P.C.
- 国际申请： PCT/IB2004/001761 WO 20040528
- 国际公布： WO2004/106299 WO 20041209
- 主分类号： C07D405/06
- IPC分类号： C07D405/06 ; C07D207/337 ; A61K31/4025 ; A61K31/40
摘要：
The present invention relates to substituted pyrrole derivatives, which can be used as 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors. Compounds disclosed herein can function as cholesterol lowering agents and can be used for the treatment of cholesterol-related diseases and related symptoms. Processes for the preparation of disclosed compounds are provided, as well as pharmaceutical compositions containing the disclosed compounds, and methods of treating cholesterol-related diseases and related symptoms.
公开/授权文献
信息查询
